Chantix

Chantix anti-smoking pill raises risk of heart attacks, says FDA

Monday, July 11, 2011 by: Sally Oaken
Tags: Chantix, heart attacks, health news

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
Chemotherapy kills cancer patients faster than no treatment at all
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Delicious
(NaturalNews) Early in June, the FDA released a report officially linking the smoking cessation drug Chantix to an increased risk of cardiovascular health problems including heart attacks.

The increased heart attack risk is low and is noted primarily among those who are already experiencing problems with their cardiovascular health, but the connection has been proven conclusively, and has led to FDA to require a new series of randomized, placebo-controlled trials which may eventually result in the removal of the drug from the market.

For the study in question, 700 smokers with cardiovascular disease participated in an independent randomized trial in which some of the subjects were treated with Chantix and some were treated with a placebo.

Chantix was proven to be effective in helping patients quit smoking for up to one year. But unfortunately, the subjects who received the drug experienced a higher incidence of adverse cardiovascular events that those who were provided with the placebo.

Chantix has previously been associated with a wide variety of other negative side effects, which have resulted in a ruling requiring Pfizer, the company that produces Chantix, to label the drug with restrictive "black box" warnings.

Many of these side effects are psychological and include agitation, depression, nightmares and suicidal thoughts. These symptoms have occurred in patients with no history of depression or mental illness, and those with an existing history of mental illness have experienced a worsening of their symptoms as they begin taking Chantix. These side effects have led to slow sales for what was originally believed to be a promising smoking cessation aid.

The Food and Drug Administration has been hesitant to place additional restrictions on Pfizer's production of Chantix due to the possibility that its benefits as a smoking cessation aid may outweigh the harm caused by its possible side effects.

As new evidence comes to light about the dangers of smoking, the FDA must balance the potential risk of the drug against the greater good it provides by lowering the rates of cancer and heart disease associated with smoking. But ironically, many of patients who begin taking Chantix are smokers who have developed heart problems and are interesting in smoking cessation to protect themselves from the risk of heart attacks.

Meanwhile, as they have been for generations, tobacco companies are engaged in vigorous efforts to reduce the stringency of labeling requirements on cigarette packaging and decrease restrictions on cigarette production and marketing.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.